Étienne Khoury

1.7k total citations
28 papers, 669 citations indexed

About

Étienne Khoury is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Étienne Khoury has authored 28 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 13 papers in Cardiology and Cardiovascular Medicine and 11 papers in Cancer Research. Recurrent topics in Étienne Khoury's work include Lipoproteins and Cardiovascular Health (17 papers), Lipid metabolism and disorders (13 papers) and Cancer, Lipids, and Metabolism (11 papers). Étienne Khoury is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Lipid metabolism and disorders (13 papers) and Cancer, Lipids, and Metabolism (11 papers). Étienne Khoury collaborates with scholars based in Canada, United States and Netherlands. Étienne Khoury's co-authors include Stéphane A. Laporte, Yoon Namkung, Michel Bouvier, Hiroyuki Kobayashi, Daniel Gaudet, Mireille Hogue, Christian Le Gouill, Viktoria Lukashova, Diane Brisson and Brandon Zimmerman and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and European Heart Journal.

In The Last Decade

Étienne Khoury

25 papers receiving 663 citations

Peers

Étienne Khoury
Sabrina T. Exum United States
Kevin M. Kaltenbronn United States
Vanessa L. Wehbi United States
C W Benjamin United States
H Ji United States
Janelle R. Keys United States
Sabrina T. Exum United States
Étienne Khoury
Citations per year, relative to Étienne Khoury Étienne Khoury (= 1×) peers Sabrina T. Exum

Countries citing papers authored by Étienne Khoury

Since Specialization
Citations

This map shows the geographic impact of Étienne Khoury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Étienne Khoury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Étienne Khoury more than expected).

Fields of papers citing papers by Étienne Khoury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Étienne Khoury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Étienne Khoury. The network helps show where Étienne Khoury may publish in the future.

Co-authorship network of co-authors of Étienne Khoury

This figure shows the co-authorship network connecting the top 25 collaborators of Étienne Khoury. A scholar is included among the top collaborators of Étienne Khoury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Étienne Khoury. Étienne Khoury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khoury, Étienne, et al.. (2024). Emerging therapies for refractory hypercholesterolemia: a narrative review. Future Cardiology. 20(5-6). 317–334.
2.
3.
Brisson, Diane, et al.. (2023). Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activity. Clinical Biochemistry. 114. 67–72. 13 indexed citations
5.
Khoury, Étienne, et al.. (2022). Atherosclerotic plaque regression in homozygous familial hypercholesterolaemia: a case report of a long-term lipid-lowering therapy involving LDL-receptor-independent mechanisms. European Heart Journal - Case Reports. 7(1). ytad029–ytad029. 6 indexed citations
6.
Schuetz, Doris A., Tomasz Maciej Stępniewski, Yoon Namkung, et al.. (2021). Discovery of a dual Ras and ARF6 inhibitor from a GPCR endocytosis screen. Nature Communications. 12(1). 4688–4688. 10 indexed citations
7.
Couture, Patrick, Jacques Genest, Isabelle L. Ruel, et al.. (2021). Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH Registry. Canadian Journal of Cardiology. 38(3). 311–319. 10 indexed citations
8.
Bélanger, A.M., Leslie Brown, Jean Bergeron, et al.. (2020). Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experience. Atherosclerosis. 310. 54–63. 13 indexed citations
9.
Tremblay, Karine, Daniel Gaudet, Étienne Khoury, & Diane Brisson. (2020). Dissection of Clinical and Gene Expression Signatures of Familial versus Multifactorial Chylomicronemia. Journal of the Endocrine Society. 4(6). bvaa056–bvaa056. 16 indexed citations
10.
Khoury, Étienne, Diane Brisson, Nathalie Roy, G Tremblay, & Daniel Gaudet. (2019). Review of the long-term safety of lomitapide: a microsomal triglycerides transfer protein inhibitor for treating homozygous familial hypercholesterolemia. Expert Opinion on Drug Safety. 18(5). 403–414. 14 indexed citations
11.
Khoury, Étienne, Daniel Gaudet, & Diane Brisson. (2019). Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activity. Journal of clinical lipidology. 13(3). e25–e26. 1 indexed citations
12.
Brunham, Liam R., Isabelle L. Ruel, Étienne Khoury, et al.. (2018). Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registry. Atherosclerosis. 277. 419–424. 22 indexed citations
13.
Paquette, Martine, Diane Brisson, Robert Dufour, et al.. (2017). Cardiovascular disease in familial hypercholesterolemia: Validation and refinement of the Montreal-FH-SCORE. Journal of clinical lipidology. 11(5). 1161–1167.e3. 41 indexed citations
14.
Beautrait, Alexandre, Justine S. Paradis, Brandon Zimmerman, et al.. (2017). A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signalling. Nature Communications. 8(1). 15054–15054. 122 indexed citations
15.
Namkung, Yoon, Christian Le Gouill, Viktoria Lukashova, et al.. (2016). Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET. Nature Communications. 7(1). 12178–12178. 232 indexed citations
16.
Gaudet, Daniel, Daniel A. Gipe, Robert Pordy, et al.. (2016). Safety and efficacy of evinacumab, a monoclonal antibody to ANGPTL3, in patients with homozygous familial hypercholesterolemia receiving concomitant lipid-lowering therapies. Journal of clinical lipidology. 10(3). 715–715. 6 indexed citations
17.
Khoury, Étienne, et al.. (2014). Allosteric and Biased G Protein-Coupled Receptor Signaling Regulation: Potentials for New Therapeutics. Frontiers in Endocrinology. 5. 68–68. 63 indexed citations
18.
Khoury, Étienne, et al.. (2014). Differential Regulation of Endosomal GPCR/β-Arrestin Complexes and Trafficking by MAPK. Journal of Biological Chemistry. 289(34). 23302–23317. 31 indexed citations
19.
Goupil, Eugénie, Étienne Khoury, Brandon Zimmerman, et al.. (2012). Biasing the Prostaglandin F2α Receptor Responses toward EGFR-Dependent Transactivation of MAPK. Molecular Endocrinology. 26(7). 1189–1202. 20 indexed citations
20.
Khoury, Étienne, et al.. (2004). FRASER OR CRYPTOPHTHALMOS SYNDROME:A CASE REPORT. 7(4). 307–309. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026